Israeli Startup Hopes to Battle Alzheimer’s

Israeli Startup Hopes to Battle Alzheimer’s

Credit:Arik Shraga

While the road ahead will be long, lab testing by Israeli researchers shows that an enzyme-inhibiting compound might slow down the progress of Alzheimer’s, reports the Times of Israel:

Israeli startup ProteKt Therapeutics is developing a drug to treat early stages of Alzheimer’s by targeting an enzyme that is believed to play a part in the development of the devastating neurodegenerative disease that causes memory loss and the inability to function.

The startup hopes that by inhibiting the enzyme, it will be able to bring about cognitive improvements in patients and slow the progress of the disease. It also hopes that the same treatment, when developed, could help with other neurodegenerative diseases such as ALS, Huntington and Parkinson’s.

Tags: Israeli Innovation

More From Fellowship Blog

Fellowship Blog

Faces of The Fellowship: Gabriel

“I really like the fact that I’m going to be living in Israel, the true home of the Jewish people,” says this week's Faces of The Fellowship!

Fellowship Blog

My Only Light in Vast Darkness: A Tatar Family of Holocaust Heroes

A Tatar mother and daughter in Belarus, Fatima and Aysha saved an entire Jewish family from certain death during the Holocaust.

Fellowship Blog

Israel Successfully Launches Ofek 16 Spy Satellite Into Space

Now in orbit, an advanced satellite will be able to monitor threats to Israel.

Subscribe to our Newsletter

Stay informed about issues affecting Israel, the Jewish people, Jewish-Christian relations, receive daily devotionals, and more.